Baxter International Inc (BAX) Shares Bought by Arizona State Retirement System

Arizona State Retirement System grew its position in shares of Baxter International Inc (NYSE:BAX) by 4.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 266,734 shares of the medical instruments supplier’s stock after buying an additional 12,196 shares during the quarter. Arizona State Retirement System’s holdings in Baxter International were worth $17,242,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the business. Checchi Capital Advisers LLC lifted its holdings in Baxter International by 16.5% during the 4th quarter. Checchi Capital Advisers LLC now owns 5,464 shares of the medical instruments supplier’s stock worth $353,000 after buying an additional 774 shares during the last quarter. DnB Asset Management AS lifted its holdings in Baxter International by 1.7% during the 4th quarter. DnB Asset Management AS now owns 54,428 shares of the medical instruments supplier’s stock worth $3,518,000 after buying an additional 900 shares during the last quarter. Goelzer Investment Management Inc. lifted its holdings in Baxter International by 13.6% during the 4th quarter. Goelzer Investment Management Inc. now owns 7,677 shares of the medical instruments supplier’s stock worth $496,000 after buying an additional 922 shares during the last quarter. Delta Asset Management LLC TN lifted its holdings in Baxter International by 0.6% during the 4th quarter. Delta Asset Management LLC TN now owns 158,724 shares of the medical instruments supplier’s stock worth $10,259,000 after buying an additional 964 shares during the last quarter. Finally, Blackhill Capital Inc. lifted its holdings in Baxter International by 0.7% during the 4th quarter. Blackhill Capital Inc. now owns 143,000 shares of the medical instruments supplier’s stock worth $9,244,000 after buying an additional 1,000 shares during the last quarter. 83.12% of the stock is currently owned by institutional investors.

In related news, SVP Jeanne K. Mason sold 33,350 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The stock was sold at an average price of $65.25, for a total value of $2,176,087.50. Following the sale, the senior vice president now directly owns 124,609 shares in the company, valued at approximately $8,130,737.25. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Giuseppe Accogli sold 28,641 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The shares were sold at an average price of $67.00, for a total value of $1,918,947.00. The disclosure for this sale can be found here. 0.05% of the stock is owned by company insiders.

Shares of Baxter International Inc (NYSE:BAX) opened at $66.03 on Thursday. The company has a current ratio of 2.80, a quick ratio of 2.22 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $35,212.48, a P/E ratio of 51.19, a PEG ratio of 1.86 and a beta of 0.78. Baxter International Inc has a 1 year low of $48.58 and a 1 year high of $72.58.

Baxter International (NYSE:BAX) last posted its earnings results on Thursday, February 1st. The medical instruments supplier reported $0.64 EPS for the quarter, beating the consensus estimate of $0.59 by $0.05. Baxter International had a return on equity of 15.12% and a net margin of 6.79%. The firm had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.77 billion. During the same period last year, the firm earned $0.57 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. research analysts predict that Baxter International Inc will post 2.78 earnings per share for the current fiscal year.

A number of research firms have commented on BAX. BMO Capital Markets increased their target price on Baxter International from $74.00 to $77.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Barclays increased their price target on Baxter International from $73.00 to $77.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Royal Bank of Canada reiterated a “hold” rating and set a $72.00 price target on shares of Baxter International in a research report on Friday, February 2nd. Zacks Investment Research upgraded Baxter International from a “sell” rating to a “hold” rating in a research report on Thursday, January 4th. Finally, Raymond James Financial upgraded Baxter International from a “market perform” rating to an “outperform” rating and set a $73.00 price target on the stock in a research report on Wednesday, January 3rd. Seven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $70.36.

COPYRIGHT VIOLATION WARNING: This article was first reported by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://www.themarketsdaily.com/2018/02/15/baxter-international-inc-bax-shares-bought-by-arizona-state-retirement-system.html.

Baxter International Profile

Baxter International Inc, through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products.

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply